Concepedia

Author

Paul Dillon

UNSW SydneyORCID

Also Known As

Dillon, Paul, John State, P Dillon, P. DILLON, P. Dillon, PAUL DILLON, Paul Dillon, Paul H. Dillon

105

Publications

4.3K

Citations

25

H-Index

95

Concepts

All Affiliations

UNSW SydneyRoyal College of Surgeons in IrelandNational Centre for Clinical Research on Emerging DrugsAlcohol and Drug FoundationRoche (Switzerland)
PD

About

Paul Dillon is an author at UNSW Sydney specializing in substance abuse, medicine, and addiction.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

16

1.6K

2

Health Sciences

11

12

1.9K

3

Arts

1

1

15

4

Education

1

1

32

5

Nursing

1

1

14

Paul Dillon

×

44

Publications

3.8K

Citations

24

H-Index

YearCitations

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal,

Gastroenterology

2013

906

Effects of backpacking holidays in Australia on alcohol, tobacco and drug use of UK residents

Mark A Bellis, Karen Hughes, Paul Dillon,

BMC Public Health

2007

523

Ecstasy use in Australia: patterns of use and associated harm

Libby Topp, Julie Hando, Paul Dillon,

Drug and Alcohol Dependence

1999

356

Patterns of use and harms associated with non-medical ketamine use

Paul Dillon

Drug and Alcohol Dependence

2003

246

GHB use among Australians: characteristics, use patterns and associated harm

Louisa Degenhardt, Shane Darke, Paul Dillon

Drug and Alcohol Dependence

2002

152

Survey of Australians using cannabis for medical purposes

Wendy Swift, Peter Gates, Paul Dillon

Harm Reduction Journal

2005

134

A computerized harm minimization prevention program for alcohol misuse and related harms: randomized controlled trial

Laura Vogl, Maree Teesson, Gavin Andrews,

Addiction

2009

110

Illicit drugs and the media: Models of media effects for use in drug policy research

Kari Lancaster, Caitlin Hughes, Bridget Spicer,

Drug and Alcohol Review

2010

109

Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma

Andrew X. Zhu, Farshid Dayyani, Chia‐Jui Yen,

Clinical Cancer Research

2022

107

Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users

Jan Copeland, Richard Peters, Paul Dillon

Drug and Alcohol Dependence

2000

102

Page 1